Clayface hits theatres on October 23, and the DCU’s latest entry into the horror genre arrives with a quietness that’s almost alarming. It’s not just another superhero film — it’s a standalone psychological horror based on one of Batman’s most enduring villains, Matt Hagen, who transforms into living clay after a botched experimental procedure meant to restore his face. The film is directed by James Watkins, known for Speak No Evil and an episode of Black Mirror, and written by Mike Flanagan, a name synonymous with modern haunted-house storytelling. Warner Bros. Pictures is distributing the movie, but there’s little sign of a campaign behind it. No viral stunts. No teaser drops. Just a sparse rollout, with no major promotional push in the weeks leading up to release. That lack of buzz is stark when compared to other DCU entries, especially Joker, which launched with a cultural earthquake. Joaquin Phoenix’s 2019 film opened to $96.2 million in North America alone, and its sequel still managed $37.7 million despite being widely panned. Clayface, meanwhile, is tracking to earn between $23 million and $33 million in its opening weekend. Less than Supergirl’s domestic debut, and far below even the second Joker’s performance. According to reports, the film has a production budget of $40 million, making it a relatively low-cost venture. But that doesn’t mean it’s safe. To break even, the movie needs to gross $100 million worldwide. Profitability requires more than that, over $100 million. So while the numbers may seem modest on paper, the financial stakes are high. A film this small can’t afford a misfire. And yet, it’s releasing around Halloween. A time when audiences lean into the macabre. That timing could be a lifeline. If the film earns strong word-of-mouth, if critics respond well, if viewers find something unsettling and compelling in the slow decay of a man becoming his own monster, then the numbers might climb. But without momentum, without visibility, the path to $100 million feels like climbing a wall with no handholds. The DCU has leaned on franchises before, but this isn’t one. This is a character study wrapped in body horror, built on dread, not spectacle. And right now, it’s flying under the radar. The question isn’t whether it’ll scare people. It’s whether anyone will notice it at all.